Epstein Secrets

the same as the last couple of years. There may be further slowing of China, but India and Indonesia could see growth accelerate, Malaysia and the Philippines could maintain trend growth, and the rest of Asia could see less disappointment. Indeed, our forecast for the next two years assumes such a path. W

5% share shrink. Ex. Energy & Financials, as much less y/y litigation expense at Banks, 2015 S&P EPS was up 6% or 10% ex. 4% FX drag. Growth led by Health Care and big consumer oriented Tech firms. We expect growth to slow at these two S&P segments, but remain key growth drivers. II2016E S&P EPS of $125 i

nce in the health system in order to enhance % of Healthcare facilities reporting comprehensive % 10 100 NA 10

nstituent of @ CHINA mw KOREA = TAIWAN @ INDIA m SOUTH AFRICA @ BRAZIL SAUD: @ MEXICO m RUSSIA = MALAYSIA (EM) m= INDONESIA ~ THAILAND m@ PHILIPPINES TURKEY © CHILE = POLAND & QATAR m UAE @ COLOMBIA = PERU m GREECE m HUNGARY EGYPT m@ CZECH REPUBLIC Source: BofA Merrill Lynch Global Resear

deserves a larger premium. ¢ We continue to like Healthcare as it offers solid long-term earnings prospects w

ces within Asia ex Japan (relative to MSCI Asia ex Japan) underweight neutral overweight China —————] Hong Kong India Indonesia | Korea a Malaysia | Philippines 7 Singapore Taiwan Thailand Others Bnew old For further information please contact ClO asset class specialist Kelvin Tay, [email protected] 20 Ple

s 11.4% 13.1% 13.8% 19.5% MSCI Europe* 1104 13.2% Healthcare 18.4% 15.5% 15.0% 30.9% MSCI EM $* oo5 12.2% Fina

T 3.0 3.0 40 40 41 45 3.9 2.2 Korea 3.6 23 3.2 25 1.1 0.6 35 3.0 40 45 40 24 19 3.0 Malaysia 51 5.0 t 3.7 t 58 59 25 3.5 T 3.5 T 3.0 3.5 3.2 d 1.1 2 Philippines 3.8 53 35 12.6 0.9 12 2 45 45 45 47 29 23 23 Singapore 49 154 2.54 95) -07 3.90 3.24 49. 1.6 T 41 55 53 4.5 T 4.0 T Taiwan 4.0 12 34 1.6 22 SS 3.8 55